Head-to-head · Cost-Efficiency Index
Novi vs Nolu
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Novi
Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site.
Visit NoviNolu
Shoppers who want GLP-1 plus an adjacent microdose or NAD+/longevity line without juggling separate accounts.
Visit NoluThe verdict
Novi takes it, leading the Cost-Efficiency Index 69 to 68. Novi is a compounded GLP-1 telehealth brand advertising semaglutide from $99/month and tirzepatide from $133/month — both framed as marked down from a $299 standing price and paired with a live countdown-timer urgency device. Nolu still earns a C — Shoppers who want GLP-1 plus an adjacent microdose or NAD+/longevity line without juggling separate accounts.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Novi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Novi | Nolu |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 68/100 |
| Semaglutide / mo | $99/mo (all doses, promotional rate, compounded) | $249 (billed per 4 weeks, ~8% above nominal monthly) |
| Tirzepatide / mo | $133/mo (all doses, promotional rate, compounded) | $339 (billed per 4 weeks, ~8% above nominal monthly) |
| Semaglutide / yr (modeled) | $1,188 | $2,988 |
| Tirzepatide / yr (modeled) | $1,596 | $4,068 |
| Coverage | Coverage not published | All 50 states + Washington, D.C. (standard eligibility hedge) |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #105 | #111 |
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, independently verifiable via the linked legitscript.com record
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- No published mg dose, supply duration, state-coverage list, named medical director, or named compounding pharmacy anywhere on the site or its help center — the least transparent operational disclosure of any company researched in this batch
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
Nolu
68/100Where the value is
- Both molecules published up front — $249 semaglutide, $339 tirzepatide — plus an oral semaglutide tablet option
- All-inclusive per-cycle pricing: consultation, medication and shipping bundled, no separate membership fee
- LegitScript verified
The tradeoffs
- Billed every 4 weeks, not per calendar month — 13 charges a year, not 12, so the real annualized cost runs ~8% above the headline figure
- No named medical director, prescriber, or compounding pharmacy disclosed anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.